Editorial: nocebo effect and switching to biosimilars.

van Bodegraven, A A

Editorial: nocebo effect and switching to biosimilars. [electronic resource] - Alimentary pharmacology & therapeutics 03 2018 - 850-851 p. digital

Publication Type: Editorial; Comment

1365-2036

10.1111/apt.14509 doi


Biosimilar Pharmaceuticals
Humans
Inflammatory Bowel Diseases
Infliximab
Nocebo Effect
Prospective Studies